1. Institute of General and Molecular Pathology, University of Tartu, Tartu, Estonia;
2. Institute of Medicine, University of Bergen, Bergen, Norway;
3. Biotherapeutics, National Institute for Biological Standards and Control, Potters Bar, United Kingdom;
4. Institute of Medical Technology, University of Tampere, Tampere, Finland;
5. Neurosciences Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom;
6. Centre for Medical Genetics and
7. Department of Pediatric Endocrinology, Diabetes and Metabolism, University Children's Hospital, Ljubljana, Slovenia;
8. Department of Medical Sciences, Uppsala University, Uppsala, Sweden;
9. Section of Endocrinology, Akershus University Hospital, University of Oslo, Oslo, Norway;
10. Pediatric Clinic II, Ospedale Microcitemico and Department of Biomedical and Biotechnological Science, University of Cagliari, Sardinia, Italy;
11. Division of Pediatric Endocrionology, UMDNJ/Robert Wood Johnson Medical School, New Brunswick, NJ;
12. Bioseek Clinics, New York, NY;
13. Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland;
14. Dermagene Oy, Tampere, Finland;
15. Division of Molecular Medicine, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;
16. Division of Molecular Pathology, Institute of Medical and Veterinary Science and the Hanson Institute, School of Medicine at the University of Adelaide, Adelaide, Australia; and
17. Department of Medicine, Haukeland University Hospital, Bergen, Norway